Brazil at a glance
- Population
- 212.8 million 2025
- Life expectancy at birth
- 76.0 years, 2024
- People aged 65 and over
- 11.5 % of people, 2025
- Health spending per person
- 1,010 US$ per person, 2023
- Doctors
- 2.36 per 1,000 people, 2023
Updated
Reviewed by Chandani Patel
Brazil Hormone Testing at Home Market Industry Trends and Forecast to 2034: Segmented by (Hormone, Sample, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$32.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $19.8 Mn | — | — |
| 2025 (base) | $21.9 Mn | +$2.1 Mn | — |
| 2026 (forecast) | $24.3 Mn | +$2.3 Mn | +10.7% |
| 2027 (forecast) | $26.9 Mn | +$2.6 Mn | +22.5% |
| 2028 (forecast) | $29.8 Mn | +$2.9 Mn | +35.7% |
| 2029 (forecast) | $32.9 Mn | +$3.2 Mn | +50.2% |
| 2030 (forecast) | $36.5 Mn | +$3.5 Mn | +66.2% |
| 2031 (forecast) | $40.4 Mn | +$3.9 Mn | +84% |
| 2032 (forecast) | $44.7 Mn | +$4.3 Mn | +103.7% |
| 2033 (forecast) | $49.5 Mn | +$4.8 Mn | +125.5% |
| 2034 (forecast) | $54.8 Mn | +$5.3 Mn | +149.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $21.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $54.8 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Hormone, sample and end user (see all) |
| Key players | Everlywell, LetsGetChecked, Thorne, Mira, Hims & Hers Health (see all) |
| Regulator in Brazil | ANVISASource: ANVISA. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
At-home hormone tests measure hormones such as estrogen, thyroid, cortisol and testosterone from finger-prick blood or saliva.
Key segments of the hormone Testing at Home market include hormone (Female Sex Hormones, Thyroid and Cortisol) and sample (Blood, Saliva and Urine).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the hormone Testing at Home market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the hormone Testing at Home market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the hormone Testing at Home market.
The hormone Testing at Home market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices are notified to or registered with ANVISA, the National Health Surveillance Agency, depending on their risk class.[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.[2]
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hormone Testing at Home products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Brazil.
What doctors and scientists are doing in Hormone Testing at Home right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.
From our blog
Brazil · 2 shared keywords
Brazil · 1 shared keyword
Brazil
Brazil
Brazil
Brazil
Digital Health · Brazil
Healthcare Services · Brazil
Healthcare Services · Brazil
Pharmaceuticals · Brazil
Pharmaceuticals · Brazil
Healthcare Services · Brazil